Filter Gallery Section: High Impact Sites
25CG – HIS – PPP
Palmoplantar psoriasis
24CG – HIS – Inverse
Plaque psoriasis
22CG – HIS
21MTT – HIS
10-year-old male patient with 2 month history of pruritic rash. Histopathologically confirmed: regular acanthosis, marked compact hyperkeratosis and parakeratosis, munro
20ND – HIS
19MM – HIS
A male patient with erythrodermic psoriasis presented with ridging, pitting, oil spots on the nails with subungual hyperkeratosis and mild
HighImpact28
A middle aged male patient presented with numerous hyperkeratotic plaque type lesions predominantly on both extremities with deformity in a
HighImpact27
Patient presented with numerous scaly plaque on almost all of her body including scalp. There was hyperkeratosis of the palms
HighImpact26
Patient has psoriasis confirmed by a skin biopsy. The patient presents with different types of lesions; plaque to patches and
HighImpact25
Patient is an Afro-Colombian woman who developed flexural psoriasis several years ago in the axillary, inframammary, inguinal and intergluteal areas.
HighImpact24
Patient is an Afro-Colombian woman who developed flexural psoriasis several years ago in the axillary, inframammary, inguinal and intergluteal areas.
HighImpact23
Patient presented to our health facility with longstanding untreated psoriasis.
HighImpact20
Patient has psoriasis confirmed by a skin biopsy. The patient presents with different types of lesions; plaque to patches and
HighImpact18
HighImpact17
HighImpact15
A middle aged male patient presents with insidious onset, gradually progressive, dark, raised lesions on hands and feet. Lesions have
HighImpact14
Patient presents with red, itchy lesions in the groin. He was repeatedly treated as tinea cruris. Examination shows well defined,
HighImpact13
A young patient presents with severe plantar psoriasis.
HighImpact12
A young patient presents with inverse plantar psoriasis.
HighImpact11
A young patient presents with severe plantar psoriasis.
Scaling28
A 32-year-old male patient presents with scalp psoriasis with rough thick scales and some cracks.
Scaling10
A 38 -year-old male patient from a rural area visited the dermatology clinic for the first time and treatment naive.
Scaling7
Patient presents with scalp psoriasis with adherent scales.
PC55
A 31-year-old male patient with plaque psoriasis. Patient presented with a prolonged history of topical steroid use, showing drug induced
PC47
A 38 -year-old male patient presented with erythematous, scaly lesions and desquamation associated with onycholysis and sub-ungual hyperkeratosis.
<div class="addtoany_share_save_container
PC14
A middle aged male presented with plaques over both feet and hands. He was treated with tapinarof 1% cream for
PC13
An elderly man presented with purplish plaques with scales that have been present on his legs for 5 years. Upon
What's New
What Comes Next in Psoriasis Treatment: A Look at the Current Pipeline
IPC Jr. Councilor Towhida Noor reviews the psoriasis pipeline: selective TYK2 inhibitors, long-acting IL-17 and IL-23 biologics, and IL-36 blockade in GPP.
Psoriasis: An Expert Global Perspective Is Now Available for Pre-Order
IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.
PRE-ORDER YOUR COPY
Thursday, September 10, 2026
New Video Resource: Early Diagnosis and Treatment of Psoriatic Arthritis (PsA)
In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.
Friday, September 25, 2026
Take Ten Video: Bridging Psoriasis and Metabolic Comorbidities
IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.